Photo from wikipedia
New transcatheter devices are being developed to reduce tricuspid regurgitation (TR) and improve clinical outcomes in selected patients. The FORMA early feasibility study (EFS) was conducted to evaluate the safety… Click to show full abstract
New transcatheter devices are being developed to reduce tricuspid regurgitation (TR) and improve clinical outcomes in selected patients. The FORMA early feasibility study (EFS) was conducted to evaluate the safety and device performance of the FORMA system (Edwards Lifesciences, Irvine, California
Keywords:
tricuspid regurgitation;
early feasibility;
feasibility study;
forma early;
transcatheter
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!